Gold Bamboo
🩺 Conditions 💊 Medications 🌿 Supplements 🧘 Modalities ⚕️ Treatments 🔬 Tests 🥗 Diets 🫀 Body Systems
Browse all health topics
Supplements East vs West Relates Health AI Practitioners List your practice Search
Login

Hepatitis B

Well-Studied

Overview

Hepatitis B is a viral infection caused by the hepatitis B virus (HBV) that primarily affects the liver. It can present as an acute infection, which may resolve on its own, or as a chronic infection, which can persist for decades and increase the risk of cirrhosis, liver failure, and hepatocellular carcinoma. HBV is transmitted through exposure to infected blood and certain body fluids, including during childbirth, sexual contact, unsafe injections, and other blood-related exposures. Because many people have few or no symptoms, hepatitis B may remain undetected until liver damage is advanced.

Globally, hepatitis B remains a major public health issue. The World Health Organization estimates that hundreds of millions of people live with chronic hepatitis B worldwide, with the burden especially high in parts of Asia and sub-Saharan Africa. Infection acquired at birth or in early childhood is more likely to become chronic than infection acquired in adulthood, which is one reason prevention efforts focus heavily on maternal screening, newborn vaccination, and broader immunization programs. In many countries, routine vaccination has significantly reduced new infections and serious complications.

The course of hepatitis B varies widely. Some individuals clear the virus after an acute illness, while others become long-term carriers with differing degrees of viral activity and liver inflammation. Chronic hepatitis B is often described in phases based on viral replication, immune response, and liver enzyme patterns, though these phases do not always follow a simple linear progression. Monitoring commonly includes HBV surface antigen, e antigen status, HBV DNA levels, liver enzymes, and liver fibrosis assessment. These markers help clinicians estimate disease activity and long-term risk.

From a broader health perspective, hepatitis B is significant not only because of the infection itself, but because of its close relationship to liver cancer prevention, maternal-child health, and health equity. Screening in high-risk populations, safe medical practices, vaccination, and appropriate long-term monitoring are central themes in public health and clinical care. People with hepatitis B often require individualized evaluation, and consultation with qualified healthcare professionals is important because disease stage, liver status, age, pregnancy status, and co-infections can all shape management decisions.

Western Medicine Perspective

Western Medicine Perspective

In conventional medicine, hepatitis B is understood as a DNA viral infection of the liver caused by HBV. After infection, the immune system's response plays a major role in determining whether the virus is cleared or persists. Adults with acute infection often recover spontaneously, while infants infected perinatally and some immunocompromised individuals have a much higher risk of chronic infection. Chronic HBV is a dynamic disease state in which ongoing viral replication and liver inflammation may contribute over time to fibrosis, cirrhosis, portal hypertension, and hepatocellular carcinoma.

Diagnosis and disease assessment rely on laboratory and imaging tools rather than symptoms alone. Common tests include HBsAg, anti-HBs, anti-HBc, HBeAg, anti-HBe, and quantitative HBV DNA, along with liver function tests such as ALT and AST. Additional evaluation may include ultrasound, elastography, or other fibrosis assessments to estimate liver scarring and cancer risk. Conventional management emphasizes prevention through vaccination, reduction of transmission risk, screening in pregnancy, and structured follow-up for people with chronic infection. Antiviral therapies such as nucleos(t)ide analogs are used in selected patients to suppress viral replication and reduce the risk of complications, although current therapies generally do not eradicate the virus completely.

Western guidelines also place strong emphasis on hepatocellular carcinoma surveillance in people with elevated risk, as well as on identifying coexisting conditions such as hepatitis D, hepatitis C, HIV, alcohol-related liver injury, and metabolic dysfunction-associated fatty liver disease. Research shows that long-term viral suppression can reduce progression to cirrhosis and lower liver cancer risk, but regular reassessment remains important because risk is not eliminated. In this model, hepatitis B is approached as a chronic infectious and liver disease requiring risk stratification, preventive care, and ongoing monitoring by trained clinicians.

Eastern & Traditional Perspective

Eastern/Traditional Medicine Perspective

In Traditional Chinese Medicine (TCM), hepatitis B is not defined by viral markers in the modern biomedical sense, but the symptom patterns and chronic liver dysfunction associated with it are often interpreted through concepts such as damp-heat in the liver and gallbladder, liver qi stagnation, spleen deficiency, blood stasis, or yin deficiency in longer-standing illness. Traditional assessment focuses on the person's overall pattern of imbalance rather than the virus alone. Herbal formulas, acupuncture, dietary regulation, and rest have historically been used with the aim of supporting systemic balance, digestive function, and the body's resilience during chronic illness.

In Ayurveda, liver disorders may be discussed through disturbances involving pitta, impaired digestion and metabolism, and accumulation of toxic byproducts described in traditional terms. Classical approaches may include individualized herbal preparations, digestive support, and lifestyle measures intended to restore balance. In naturopathic and integrative medicine frameworks, attention is often given to liver support, nutrition, inflammation, stress, and whole-person health, while recognizing the importance of biomedical monitoring.

The evidence base for traditional approaches in hepatitis B is mixed and generally less robust than that for vaccination, antiviral therapy, and standard surveillance. Some studies have explored Chinese herbal medicine, acupuncture, and integrative treatment models for effects on liver enzymes, symptoms, or virologic markers, but findings are often limited by heterogeneous study design, varying product quality, small sample sizes, and inconsistent methodology. Because hepatitis B can progress silently and may carry serious long-term risks, traditional approaches are most responsibly framed as complementary areas of interest rather than substitutes for medical evaluation. Collaboration with qualified healthcare practitioners is important, particularly because some herbal products may affect the liver or interact with medications.

Related Topics

How They Relate

Condition / Condition

Hepatitis B & Liver Cancer (Hepatocellular Carcinoma)

Hepatitis B virus (HBV) infection is one of the most important causes of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. The link is both biological and epidemiologica...

Evidence & Sources

Well-Studied

Supported by multiple clinical trials and systematic reviews

  1. World Health Organization (WHO) Hepatitis B Fact Sheets and Guidelines
  2. Centers for Disease Control and Prevention (CDC) Hepatitis B Clinical and Public Health Guidance
  3. American Association for the Study of Liver Diseases (AASLD) Practice Guidance for Hepatitis B
  4. European Association for the Study of the Liver (EASL) Clinical Practice Guidelines on Hepatitis B
  5. The Lancet Gastroenterology & Hepatology
  6. New England Journal of Medicine
  7. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  8. National Center for Complementary and Integrative Health (NCCIH)

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.